Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s00213-010-1900-1, but it redirected us to https://link.springer.com/article/10.1007/s00213-010-1900-1. The analysis below is for the second page.

Title[redir]:
Genetics of caffeine consumption and responses to caffeine | Psychopharmacology
Description:
Rationale Caffeine is widely consumed in foods and beverages and is also used for a variety of medical purposes. Despite its widespread use, relatively little is understood regarding how genetics affects consumption, acute response, or the long-term effects of caffeine. Objective This paper reviews the literature on the genetics of caffeine from the following: (1) twin studies comparing heritability of consumption and of caffeine-related traits, including withdrawal symptoms, caffeine-induced insomnia, and anxiety, (2) association studies linking genetic polymorphisms of metabolic enzymes and target receptors to variations in caffeine response, and (3) case-control and prospective studies examining relationship between polymorphisms associated with variations in caffeine response to risks of Parkinson’s and cardiovascular diseases in habitual caffeine consumers. Results Twin studies find the heritability of caffeine-related traits to range between 0.36 and 0.58. Analysis of polysubstance use shows that predisposition to caffeine use is highly specific to caffeine itself and shares little common disposition to use of other substances. Genome association studies link variations in adenosine and dopamine receptors to caffeine-induced anxiety and sleep disturbances. Polymorphism in the metabolic enzyme cytochrome P-450 is associated with risk of myocardial infarction in caffeine users. Conclusion Modeling based on twin studies reveals that genetics plays a role in individual variability in caffeine consumption and in the direct effects of caffeine. Both pharmacodynamic and pharmacokinetic polymorphisms have been linked to variation in response to caffeine. These studies may help guide future research in the role of genetics in modulating the acute and chronic effects of caffeine.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 80,473,390 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

google, scholar, pubmed, cas, caffeine, adenosine, effects, receptor, coffee, genetic, consumption, pharmacol, disease, receptors, clin, genetics, psychiatry, studies, anxiety, risk, article, twin, association, parkinsons, intake, gene, alcohol, response, polymorphisms, cardiovascular, role, panic, res, ther, neurosci, cypa, psychopharmacology, wit, dopamine, sleep, polymorphism, variation, chronic, study, disorder, med, brain, gen, genet, review,

Topics {✒️}

month download article/chapter nas-nrc twin registry central nervous-system—interaction de-melo-neto vl population-based twin study harriet de wit long-term cardiovascular effects systematic mutation screening low-dose caffeine discrimination short-term regular consumption privacy choices/manage cookies adenosine a2a receptor coffee-attributed sleep disturbance a2a receptor activation explore cyp1a2 d2 dopamine receptors full article pdf adenosine 2a receptor adenosine a2a receptors cardiovascular disease access guide future research cytochrome p4501a induction central nervous system xanthine oxidase activities eliana luisi ml adenosine a1 receptor kendler ks adenosine a2 receptors beta-receptor agonists twin studies reveals multivariate genetic analysis brain adenosine receptors swan ge bertino js jr population based sample article psychopharmacology aims neuropsychiatr genet 139b neuropsychiatr genet 141b european economic area exposure assessment considerations menstrual cycle phase navy seal training sea–air–land rat cerebrocortical synaptosomes potentially “druggable” targets fook-chong smc genetics affects consumption case-control study long-term effects inter-individual variation

Questions {❓}

  • Kawachi I, Colditz GA, Stone CB (1994) Does coffee drinking increase the risk of coronary heart disease?
  • Kendler KS, Heath AC, Martin NG, Eaves LJ (1987) Symptoms of anxiety and symptoms of depression: same genes, different environments?
  • Maia L, de Mendonca A (2002) Does caffeine intake protect from Alzheimer’s disease?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Genetics of caffeine consumption and responses to caffeine
         description:Caffeine is widely consumed in foods and beverages and is also used for a variety of medical purposes. Despite its widespread use, relatively little is understood regarding how genetics affects consumption, acute response, or the long-term effects of caffeine. This paper reviews the literature on the genetics of caffeine from the following: (1) twin studies comparing heritability of consumption and of caffeine-related traits, including withdrawal symptoms, caffeine-induced insomnia, and anxiety, (2) association studies linking genetic polymorphisms of metabolic enzymes and target receptors to variations in caffeine response, and (3) case-control and prospective studies examining relationship between polymorphisms associated with variations in caffeine response to risks of Parkinson’s and cardiovascular diseases in habitual caffeine consumers. Twin studies find the heritability of caffeine-related traits to range between 0.36 and 0.58. Analysis of polysubstance use shows that predisposition to caffeine use is highly specific to caffeine itself and shares little common disposition to use of other substances. Genome association studies link variations in adenosine and dopamine receptors to caffeine-induced anxiety and sleep disturbances. Polymorphism in the metabolic enzyme cytochrome P-450 is associated with risk of myocardial infarction in caffeine users. Modeling based on twin studies reveals that genetics plays a role in individual variability in caffeine consumption and in the direct effects of caffeine. Both pharmacodynamic and pharmacokinetic polymorphisms have been linked to variation in response to caffeine. These studies may help guide future research in the role of genetics in modulating the acute and chronic effects of caffeine.
         datePublished:2010-06-09T00:00:00Z
         dateModified:2010-06-09T00:00:00Z
         pageStart:245
         pageEnd:257
         sameAs:https://doi.org/10.1007/s00213-010-1900-1
         keywords:
            Caffeine
            Adenosine
            Dopamine
            Genetic polymorphism
             CYP1A2
            Parkinson’s cardiovascular disease
            Neurosciences
            Pharmacology/Toxicology
            Psychiatry
         image:
         isPartOf:
            name:Psychopharmacology
            issn:
               1432-2072
               0033-3158
            volumeNumber:211
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Amy Yang
               affiliation:
                     name:University of Chicago
                     address:
                        name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Abraham A. Palmer
               affiliation:
                     name:University of Chicago
                     address:
                        name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
                     name:The University of Chicago
                     address:
                        name:Department of Human Genetics, The University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Harriet de Wit
               affiliation:
                     name:University of Chicago
                     address:
                        name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Genetics of caffeine consumption and responses to caffeine
      description:Caffeine is widely consumed in foods and beverages and is also used for a variety of medical purposes. Despite its widespread use, relatively little is understood regarding how genetics affects consumption, acute response, or the long-term effects of caffeine. This paper reviews the literature on the genetics of caffeine from the following: (1) twin studies comparing heritability of consumption and of caffeine-related traits, including withdrawal symptoms, caffeine-induced insomnia, and anxiety, (2) association studies linking genetic polymorphisms of metabolic enzymes and target receptors to variations in caffeine response, and (3) case-control and prospective studies examining relationship between polymorphisms associated with variations in caffeine response to risks of Parkinson’s and cardiovascular diseases in habitual caffeine consumers. Twin studies find the heritability of caffeine-related traits to range between 0.36 and 0.58. Analysis of polysubstance use shows that predisposition to caffeine use is highly specific to caffeine itself and shares little common disposition to use of other substances. Genome association studies link variations in adenosine and dopamine receptors to caffeine-induced anxiety and sleep disturbances. Polymorphism in the metabolic enzyme cytochrome P-450 is associated with risk of myocardial infarction in caffeine users. Modeling based on twin studies reveals that genetics plays a role in individual variability in caffeine consumption and in the direct effects of caffeine. Both pharmacodynamic and pharmacokinetic polymorphisms have been linked to variation in response to caffeine. These studies may help guide future research in the role of genetics in modulating the acute and chronic effects of caffeine.
      datePublished:2010-06-09T00:00:00Z
      dateModified:2010-06-09T00:00:00Z
      pageStart:245
      pageEnd:257
      sameAs:https://doi.org/10.1007/s00213-010-1900-1
      keywords:
         Caffeine
         Adenosine
         Dopamine
         Genetic polymorphism
          CYP1A2
         Parkinson’s cardiovascular disease
         Neurosciences
         Pharmacology/Toxicology
         Psychiatry
      image:
      isPartOf:
         name:Psychopharmacology
         issn:
            1432-2072
            0033-3158
         volumeNumber:211
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Amy Yang
            affiliation:
                  name:University of Chicago
                  address:
                     name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Abraham A. Palmer
            affiliation:
                  name:University of Chicago
                  address:
                     name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
                  name:The University of Chicago
                  address:
                     name:Department of Human Genetics, The University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Harriet de Wit
            affiliation:
                  name:University of Chicago
                  address:
                     name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Psychopharmacology
      issn:
         1432-2072
         0033-3158
      volumeNumber:211
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Chicago
      address:
         name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
         type:PostalAddress
      name:University of Chicago
      address:
         name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
         type:PostalAddress
      name:The University of Chicago
      address:
         name:Department of Human Genetics, The University of Chicago, Chicago, USA
         type:PostalAddress
      name:University of Chicago
      address:
         name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Amy Yang
      affiliation:
            name:University of Chicago
            address:
               name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Abraham A. Palmer
      affiliation:
            name:University of Chicago
            address:
               name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
            name:The University of Chicago
            address:
               name:Department of Human Genetics, The University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Harriet de Wit
      affiliation:
            name:University of Chicago
            address:
               name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
      name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
      name:Department of Human Genetics, The University of Chicago, Chicago, USA
      name:Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(387)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

4.76s.